XML 47 R37.htm IDEA: XBRL DOCUMENT v3.22.2
LICENSE AGREEMENT - Miami University (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 20 Months Ended
Dec. 14, 2020
Oct. 28, 2020
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Dec. 31, 2021
Agreements                
Research and development     $ 15,396 $ 14,802 $ 30,426 $ 29,250    
Operating expenses     21,521 25,875 44,622 50,074    
General and administrative     6,125 11,073 14,196 20,824    
Accrued expenses and other current liabilities     17,787   17,787   $ 17,787 $ 16,559
Accounts payable     8,691   8,691   8,691 9,461
2020 license agreement | University of Miami                
Agreements                
Amount of first payment to be made for license issue fee   $ 1,100            
Amount of second payment to be made for license issue fee, due on first anniversary of the date of license   500            
Payment to be made on achievement of specified patenting and development milestones   2,200            
Payment to be made on achievement of late stage regulatory milestones   $ 4,100            
Agreement term   10 years            
Written notice period for termination of agreement   60 days            
Written notice period of material breach leading to termination   60 days            
Research and development     25 25 50 50    
Operating expenses             2,300  
General and administrative     2 0 2 0    
Accrued expenses and other current liabilities     200   200   200 300
2020 license agreement | University of Miami | Minimum                
Agreements                
Royalties payment (as a percent)   0.88%            
Non-royalty sublicensing revenue payment (as a percent)   15.00%            
2020 license agreement | University of Miami | Maximum                
Agreements                
Royalties payment (as a percent)   5.00%            
Non-royalty sublicensing revenue payment (as a percent)   25.00%            
2020 research agreement and amendment | University of Miami                
Agreements                
Consideration $ 300              
Research and development     11 $ 100 48 $ 100    
Accrued expenses and other current liabilities     $ 100   $ 100   $ 100 $ 200